Home LiteratureArticle Details
PMID: 7695288 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Resistance of Candida species to fluconazole.

Antimicrobial agents and chemotherapy ·Vol. 39 ·No. 1 ·1995-01-00 ·Pages 1-8

Rex JH, Rinaldi MG, Pfaller MA

Abstract

暂无摘要

MeSH Terms
Candida/drug effects Candidiasis/drug therapy Drug Resistance, Microbial Fluconazole/pharmacology Humans Microbial Sensitivity Tests
Chemicals
Fluconazole
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rex J H
Department of Internal Medicine, University of Texas Medical School, Houston.
Rinaldi M G
Pfaller M A
References (76)
76 references, click to expand
  1. Resistance of yeasts to azole-derivative antifungals.
    J Antimicrob Chemother. 1993 Apr;31(4):463-71 PMID: 8514644
  2. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
    Antimicrob Agents Chemother. 1993 Sep;37(9):1847-9 PMID: 8239594
  3. Fluconazole resistance in Candida glabrata.
    Antimicrob Agents Chemother. 1993 Sep;37(9):1962-5 PMID: 8239613
  4. Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients.
    Eur J Epidemiol. 1993 Jul;9(4):455-6 PMID: 8243605
  5. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.
    J Clin Microbiol. 1993 Nov;31(11):2933-7 PMID: 7903316
  6. Antifungal susceptibility testing.
    Clin Microbiol Rev. 1993 Oct;6(4):367-81 PMID: 8269392
  7. Fluconazole-resistant Candida in AIDS patients. Report of two cases.
    Oral Surg Oral Med Oral Pathol. 1993 Dec;76(6):711-5 PMID: 8284074
  8. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group.
    Antimicrob Agents Chemother. 1993 Nov;37(11):2443-8 PMID: 8285631
  9. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.
    Antimicrob Agents Chemother. 1993 Nov;37(11):2449-53 PMID: 8285632
  10. Fluconazole-resistant Candida albicans.
    Clin Infect Dis. 1993 Dec;17(6):1018-21 PMID: 8110924
  11. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
    Am J Gastroenterol. 1994 Mar;89(3):416-20 PMID: 8122656
  12. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
    J Clin Microbiol. 1994 Jan;32(1):59-64 PMID: 7907345
  13. Drug interactions with fluconazole.
    Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S327-33 PMID: 2330488
  14. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.
    Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S364-8 PMID: 2184513
  15. The triazole antifungal agents: a review of itraconazole and fluconazole.
    Pharmacotherapy. 1990;10(2):146-53 PMID: 2161523
  16. High dose oral fluconazole for oropharyngeal candidosis in AIDS.
    J Antimicrob Chemother. 1990 Apr;25(4):720-1 PMID: 2351637
  17. Fluconazole or amphotericin for candidosis in neutropenic patients.
    Lancet. 1991 Jan 19;337(8734):181 PMID: 1670824
  18. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis.
    J Infect Dis. 1991 Feb;163(2):420-1 PMID: 1988531
  19. Prophylactic oral fluconazole and candida fungaemia.
    Lancet. 1991 Mar 30;337(8744):790 PMID: 1672408
  20. Fluconazole resistant candida in AIDS.
    J Infect. 1991 Mar;22(2):201-4 PMID: 2026897
  21. Candida albicans resistance in AIDS.
    J Infect. 1991 Mar;22(2):204-5 PMID: 2026898
  22. Fluconazole or amphotericin for candidaemia in non-neutropenic patients?
    Lancet. 1991 Jun 29;337(8757):1605-6 PMID: 1675729
  23. Failure of fluconazole therapy in Candida krusei fungemia.
    Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):173 PMID: 2060520
  24. Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography.
    Antimicrob Agents Chemother. 1991 May;35(5):846-50 PMID: 1854166
  25. Persistence of Cryptococcus neoformans in the prostate: failure of fluconazole despite high doses.
    J Infect Dis. 1991 Aug;164(2):435-6 PMID: 1856498
  26. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.
    J Clin Microbiol. 1991 Jun;29(6):1089-94 PMID: 1864923
  27. Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levels.
    J Infect. 1991 Jul;23(1):101-3 PMID: 1885907
  28. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole.
    Eur J Clin Microbiol Infect Dis. 1991 Jul;10(7):598-9 PMID: 1915408
  29. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
    N Engl J Med. 1991 Oct 31;325(18):1274-7 PMID: 1669837
  30. Fluconazole and Candida krusei fungemia.
    N Engl J Med. 1991 Oct 31;325(18):1315 PMID: 1922232
  31. [Resistance to fluconazole in hospitalized patients. Concordance between Candida albicans resistance in vitro and therapeutic failure].
    Presse Med. 1991 Sep 14;20(28):1341 PMID: 1833741
  32. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.
    Am J Med. 1991 Sep 16;91(3B):86S-89S PMID: 1928197
  33. Fluconazole and Candida krusei infections.
    J Hosp Infect. 1991 Aug;18(4):326-7 PMID: 1682374
  34. Fluconazole failure in the treatment of invasive mycoses.
    J Infect Dis. 1991 Dec;164(6):1232-5 PMID: 1955725
  35. Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
    Am J Gastroenterol. 1991 Dec;86(12):1729-34 PMID: 1962617
  36. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
    Arch Intern Med. 1991 Dec;151(12):2458-64 PMID: 1747004
  37. Fluconazole resistant candida in AIDS.
    J Infect. 1991 Nov;23(3):345-6 PMID: 1753152
  38. Development of resistance in candida isolates from patients receiving prolonged antifungal therapy.
    Antimicrob Agents Chemother. 1991 Nov;35(11):2302-5 PMID: 1804002
  39. Vulvovaginal candidiasis refractory to treatment with fluconazole.
    Eur J Obstet Gynecol Reprod Biol. 1992 Mar 23;44(1):77-80 PMID: 1587371
  40. Fluconazole resistance in AIDS patients.
    J Antimicrob Chemother. 1991 Dec;28(6):937-9 PMID: 1816193
  41. Yeast perinephric abscess: report of a case and review.
    Clin Infect Dis. 1992 Jul;15(1):128-33 PMID: 1617052
  42. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.
    Antimicrob Agents Chemother. 1992 Mar;36(3):690-2 PMID: 1622188
  43. [Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures].
    Pathol Biol (Paris). 1992 May;40(5):513-7 PMID: 1495836
  44. Disseminated fungal disease resistant to fluconazole treatment in a child with leukemia.
    Scand J Infect Dis. 1992;24(3):391-3 PMID: 1509246
  45. Failure of fluconazole in systemic candidiasis.
    Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):201-2 PMID: 1396741
  46. Characterization of an azole-resistant Candida glabrata isolate.
    Antimicrob Agents Chemother. 1992 Dec;36(12):2602-10 PMID: 1482129
  47. Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
    J Chemother. 1992 Dec;4(6):381-6 PMID: 1287140
  48. Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.
    J Infect. 1993 Mar;26(2):117-25 PMID: 8473758
  49. Treatment of Candida albicans fungaemia with fluconazole.
    J Infect. 1993 Mar;26(2):133-46 PMID: 8473760
  50. Fluconazole-resistant Candida albicans after long-term suppressive therapy.
    Arch Intern Med. 1993 May 10;153(9):1122-4 PMID: 8481078
  51. Candida krusei fungemia. Report of 4 cases and review of the literature.
    Medicine (Baltimore). 1993 May;72(3):143-50 PMID: 8502167
  52. Resistance of Candida albicans to azole antifungal agents.
    Biochem Soc Trans. 1993 Nov;21(4):1039-47 PMID: 8131894
  53. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
    Clin Infect Dis. 1994 Feb;18(2):240-2 PMID: 8161633
  54. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.
    Eur J Clin Microbiol Infect Dis. 1993 Dec;12(12):911-5 PMID: 8187785
  55. Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.
    Clin Infect Dis. 1994 Mar;18(3):298-304 PMID: 8011807
  56. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.
    J Clin Microbiol. 1994 Apr;32(4):1115-8 PMID: 8027327
  57. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
    J Infect Dis. 1994 Aug;170(2):384-9 PMID: 8035024
  58. Failure of fluconazole therapy for sternal osteomyelitis due to Candida albicans.
    Clin Infect Dis. 1994 Jan;18(1):126-7 PMID: 8054430
  59. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
    AIDS. 1994 May;8(5):708-9 PMID: 8060555
  60. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.
    Infection. 1994 Mar-Apr;22(2):132-6 PMID: 8070927
  61. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period.
    Antimicrob Agents Chemother. 1994 Jun;38(6):1422-4 PMID: 8092849
  62. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
    N Engl J Med. 1994 Nov 17;331(20):1325-30 PMID: 7935701
  63. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.
    Am J Med. 1994 Oct;97(4):339-46 PMID: 7942935
  64. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Antimicrob Agents Chemother. 1994 Jul;38(7):1530-3 PMID: 7979284
  65. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
    Antimicrob Agents Chemother. 1995 Jan;39(1):40-4 PMID: 7695326
  66. In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance.
    J Infect Dis. 1981 Oct;144(4):380-5 PMID: 7288218
  67. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
    Am J Med. 1983 Jan 24;74(1B):23-9 PMID: 6295149
  68. In-vitro resistance to imidazole antifungals in Candida albicans.
    J Antimicrob Chemother. 1984 Jun;13(6):547-58 PMID: 6381460
  69. Azole resistance in Candida albicans.
    J Med Vet Mycol. 1986 Apr;24(2):133-44 PMID: 3014106
  70. Azole antifungal agents: emphasis on new triazoles.
    Antimicrob Agents Chemother. 1988 Jan;32(1):1-8 PMID: 2831809
  71. Current concepts. Treatment of infections associated with human immunodeficiency virus.
    N Engl J Med. 1988 Jun 2;318(22):1439-48 PMID: 3285211
  72. Fluconazole resistance in Candida glabrata.
    Lancet. 1988 Dec 3;2(8623):1310 PMID: 2904031
  73. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus.
    J Clin Microbiol. 1988 Dec;26(12):2626-31 PMID: 3068254
  74. Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.
    Antimicrob Agents Chemother. 1989 May;33(5):714-6 PMID: 2546489
  75. Pharmacokinetics and tissue penetration of fluconazole in humans.
    Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S318-26 PMID: 2184510
  76. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
    Genitourin Med. 1993 Apr;69(2):112-4 PMID: 8389723
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
DOI
10.1128/AAC.39.1.1
Published
1995-01-00
Pages
1-8
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC162475
Subset
IM
External Links
PubMed source DOI: 10.1128/AAC.39.1.1 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2